BIOMAT Database Logo BIOMAT Database Logo

Silent thyroiditis associated with short-term lithium therapy. 2002

Shusuke Numata, and Kyoko Taniguchi, and Takashi Harada, and Masahito Tomotake, and Tetsuro Ohmori

UI MeSH Term Description Entries
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002997 Clomipramine A tricyclic antidepressant similar to IMIPRAMINE that selectively inhibits the uptake of serotonin in the brain. It is readily absorbed from the gastrointestinal tract and demethylated in the liver to form its primary active metabolite, desmethylclomipramine. Chlorimipramine,Anafranil,Chlomipramine,Clomipramine Hydrochloride,Clomipramine Maleate (1:1),Clomipramine Monohydrochloride,Hydiphen,Hydrochloride, Clomipramine,Monohydrochloride, Clomipramine
D003521 Cyclopropanes Three-carbon cycloparaffin cyclopropane (the structural formula (CH2)3) and its derivatives.
D003863 Depression Depressive states usually of moderate intensity in contrast with MAJOR DEPRESSIVE DISORDER present in neurotic and psychotic disorders. Depressive Symptoms,Emotional Depression,Depression, Emotional,Depressive Symptom,Symptom, Depressive
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000078764 Milnacipran A cyclopropanecarboxamide serotonin and norepinephrine reuptake inhibitor (SNRI) that is used in the treatment of FIBROMYALGIA. 1-Phenyl-1-diethylaminocarbonyl-2-aminomethylcyclopropane HCl,F 2207,F-2207,Ixel,Midalcipran,Milnacipran Hydrochloride,Savella,1 Phenyl 1 diethylaminocarbonyl 2 aminomethylcyclopropane HCl,F2207
D000928 Antidepressive Agents Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. Antidepressant,Antidepressant Drug,Antidepressant Medication,Antidepressants,Antidepressive Agent,Thymoanaleptic,Thymoanaleptics,Thymoleptic,Thymoleptics,Antidepressant Drugs,Agent, Antidepressive,Drug, Antidepressant,Medication, Antidepressant
D013966 Thyroiditis Inflammatory diseases of the THYROID GLAND. Thyroiditis can be classified into acute (THYROIDITIS, SUPPURATIVE), subacute (granulomatous and lymphocytic), chronic fibrous (Riedel's), chronic lymphocytic (HASHIMOTO DISEASE), transient (POSTPARTUM THYROIDITIS), and other AUTOIMMUNE THYROIDITIS subtypes. Thyroiditides

Related Publications

Shusuke Numata, and Kyoko Taniguchi, and Takashi Harada, and Masahito Tomotake, and Tetsuro Ohmori
Lithium-associated silent thyroiditis: clinical implications.
October 2013, The Australian and New Zealand journal of psychiatry,
Shusuke Numata, and Kyoko Taniguchi, and Takashi Harada, and Masahito Tomotake, and Tetsuro Ohmori
[Silent thyroiditis in a patient under lithium therapy].
January 2007, La Revue de medecine interne,
Shusuke Numata, and Kyoko Taniguchi, and Takashi Harada, and Masahito Tomotake, and Tetsuro Ohmori
Primary anetoderma associated with silent thyroiditis.
October 2016, Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia,
Shusuke Numata, and Kyoko Taniguchi, and Takashi Harada, and Masahito Tomotake, and Tetsuro Ohmori
Lithium-associated thyroiditis.
January 2002, Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists,
Shusuke Numata, and Kyoko Taniguchi, and Takashi Harada, and Masahito Tomotake, and Tetsuro Ohmori
Lithium associated autoimmune thyroiditis.
February 1997, Journal of clinical pathology,
Shusuke Numata, and Kyoko Taniguchi, and Takashi Harada, and Masahito Tomotake, and Tetsuro Ohmori
Silent thyroiditis associated with etanercept in rheumatoid arthritis.
June 2002, Annals of the rheumatic diseases,
Shusuke Numata, and Kyoko Taniguchi, and Takashi Harada, and Masahito Tomotake, and Tetsuro Ohmori
Association between lithium use and thyrotoxicosis caused by silent thyroiditis.
October 2001, Clinical endocrinology,
Shusuke Numata, and Kyoko Taniguchi, and Takashi Harada, and Masahito Tomotake, and Tetsuro Ohmori
Granulomatous thyroiditis and lithium therapy.
February 1992, Australian and New Zealand journal of medicine,
Shusuke Numata, and Kyoko Taniguchi, and Takashi Harada, and Masahito Tomotake, and Tetsuro Ohmori
[Postpartum thyroiditis: silent thyroiditis].
April 1991, Presse medicale (Paris, France : 1983),
Shusuke Numata, and Kyoko Taniguchi, and Takashi Harada, and Masahito Tomotake, and Tetsuro Ohmori
A case of rheumatoid arthritis associated with silent thyroiditis.
May 1992, Journal of endocrinological investigation,
Copied contents to your clipboard!